Cargando…
FK506 Attenuates the MRP1-Mediated Chemoresistant Phenotype in Glioblastoma Stem-Like Cells
Poor response to current treatments for glioblastoma has been attributed to the presence of glioblastoma stem-like cells (GSCs). GSCs are able to expel antitumor drugs to the extracellular medium using the multidrug resistance-associated protein 1 (MRP1) transporter. Tacrolimus (FK506) has been iden...
Autores principales: | Torres, Ángelo, Arriagada, Valentina, Erices, José Ignacio, Toro, María de los Ángeles, Rocha, José Dellis, Niechi, Ignacio, Carrasco, Cristian, Oyarzún, Carlos, Quezada, Claudia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6164673/ https://www.ncbi.nlm.nih.gov/pubmed/30208561 http://dx.doi.org/10.3390/ijms19092697 |
Ejemplares similares
-
A(2B) Adenosine Receptor Enhances Chemoresistance of Glioblastoma Stem-Like Cells under Hypoxia: New Insights into MRP3 Transporter Function
por: Rocha, José-Dellis, et al.
Publicado: (2022) -
The Adenosine A(3) Receptor Regulates Differentiation of Glioblastoma Stem-Like Cells to Endothelial Cells under Hypoxia
por: Rocha, René, et al.
Publicado: (2018) -
Adenosine Depletion as A New Strategy to Decrease Glioblastoma Stem-Like Cells Aggressiveness
por: Niechi, Ignacio, et al.
Publicado: (2019) -
Adapt to Persist: Glioblastoma Microenvironment and Epigenetic Regulation on Cell Plasticity
por: Uribe, Daniel, et al.
Publicado: (2022) -
Interactions of FK506 and Rapamycin With FK506 Binding Protein 12 in Opportunistic Human Fungal Pathogens
por: Vellanki, Sandeep, et al.
Publicado: (2020)